Evidence map›Paper›PMID 40489049›Full record

ArticleCanadian journal of public health = Revue canadienne de sante publique2025

Examining opioid agonist treatment (OAT) site operations and early signals of change in the first year of British Columbia's drug decriminalization policy: Insights from a provincial survey.

Cayley Russell, Justine Law, Kate Hodgson, Laura MacKinnon, Rita Shahin, Frank Crichlow, Sean Patenaude, Sameer Imtiaz, Jürgen Rehm, Farihah Ali

Abstract read
In one paragraph

Article in Canadian journal of public health = Revue canadienne de sante publique, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Responding to the toxic drug crisis: Promising innovations, gaps, and calls to action.Canadian journal of public health = Revue canadienne de sante publique · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Cayley RussellInstitute for Mental Health Policy Research (IMHPR), Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada. Cayley.Russell@camh.ca.ORCID 0000-0001-9634-9554
Justine LawInstitute for Mental Health Policy Research (IMHPR), Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Kate HodgsonDepartment of Nurse Practitioners, Vancouver Coastal Health, Vancouver, BC, Canada.
Laura MacKinnonUniversity of British Columbia (UBC), First Nations Health Authority (FNHA), Vancouver, BC, Canada.
Rita ShahinToronto Public Health, Toronto, ON, Canada.
Frank CrichlowCanadian Association of People Who Use Drugs (CAPUD), Dartmouth, NS, Canada.
Sean PatenaudeDepartment of Patient and Family Experience, Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Sameer ImtiazInstitute for Mental Health Policy Research (IMHPR), Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Jürgen RehmInstitute for Mental Health Policy Research (IMHPR), Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.
Farihah AliInstitute for Mental Health Policy Research (IMHPR), Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada.

Funding

Mentoring the next generation of addiction clinician scientists while responding to the opioid epidemicR25DA037756 · NIDA · UNIVERSITY OF BRITISH COLUMBIA · PI FAIRBAIRN, NADIA · 2014 to 2023
$3.6M
CIHRNIDA NIH HHS R25 DA037756
6 · The paper itself

Abstract

objectiveOn January 31, 2023, the province of British Columbia (BC) introduced a 3-year drug decriminalization initiative, with a goal of increasing access, engagement, and retention in drug use treatment. There is limited information on the operational characteristics of opioid agonist treatment (OAT) sites in BC. These data are required to monitor the impacts of decriminalization on these outcomes. This study sought to characterize OAT service operations and examine any preliminary operational changes following decriminalization, from the perspectives of OAT site staff.

methodsBetween March and April 2024, a cross-sectional, online self-report survey was distributed to OAT sites across BC, completed by site representatives. Questions focused on OAT service operations, including service capacity, treatment retention, and clientele demographics, as well as potential changes to service operations due to decriminalization. Data were analyzed descriptively.

resultsA total of 28 OAT sites from across BC completed the survey. Findings suggest that decriminalization has had limited impacts on OAT site operations within the first year of the policy's implementation. However, several sites reported early signals of change related to client socio-demographics, including seeing more male and younger clients, as well as an increase in demand on their staff and resources.

conclusionDespite minimal changes to OAT site operations within the first year of BC's decriminalization policy, findings suggest the need for increased staff training on decriminalization and continued investments into OAT to better support the anticipated demand on services if decriminalization is to successfully reach its goal of improving access to treatment.

Indexed as

Analgesics, OpioidHealth PolicyOpioid-Related DisordersSubstance Abuse Treatment CentersAdultBritish ColumbiaCross-Sectional StudiesFemaleHumansMaleSurveys and QuestionnairesAnalgesics, OpioidDecriminalizationDrug policyOpioid agonist treatment (OAT)People who use drugsPharmacotherapyPublic health

Identifiers

PMID40489049
PMCPMC12627284

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.